Valuation: FDC Limited

Market Cap 5.23TCr 54Cr 47Cr 44Cr 40Cr 76Cr 78Cr 523.41Cr 205.87Cr 2.56TCr 203.93Cr 199.46Cr 8.82TCr P/E 2024
22.8x
P/E 2025 24.1x
Enterprise Value 4.71TCr 49Cr 43Cr 39Cr 36Cr 69Cr 70Cr 471.87Cr 185.6Cr 2.31TCr 183.85Cr 179.82Cr 7.95TCr EV / Sales 2024
3.32x
EV / Sales 2025 2.8x
Free-Float
30.05%
Yield 2024 *
-
Yield 2025 1.27%
1 day-0.52%
1 week-2.81%
Current month-0.87%
1 month+9.13%
3 months+17.88%
6 months+9.11%
Current year-0.85%
1 week 414.1
Extreme 414.1
434.45
1 month 380.7
Extreme 380.7
442
Current year 314.75
Extreme 314.75
442
1 year 314.75
Extreme 314.75
528.3
3 years 314.75
Extreme 314.75
659
5 years 229.15
Extreme 229.15
659
10 years 148.2
Extreme 148.2
659
Manager TitleAgeSince
Chief Executive Officer 90 19/11/2009
Chief Executive Officer 63 30/09/1993
Director of Finance/CFO - 24/10/2025
Director TitleAgeSince
Director/Board Member 48 01/01/2002
Director/Board Member 63 30/09/1993
Chairman 90 16/11/2009
Change 5-day change 1-year change 3-year change Capi.($)
-0.52%-2.81%-15.43%+27.16% 71Cr
+0.31%-1.18%+54.25%+162.69% 1,04300Cr
+1.17%-1.54%+55.25%+59.07% 60TCr
+0.53%+3.22%+33.79%+89.92% 45TCr
+0.78%-0.71%+30.04%+24.61% 33TCr
+1.41%+0.58%+33.92%+47.20% 28TCr
-0.27%-1.87%+22.13%+23.47% 26TCr
-2.41%-0.15%+21.66%+59.26% 20TCr
-1.19%+3.94%+24.03%+74.16% 17TCr
-0.38%+3.62%+1.89%-30.16% 14TCr
Average -0.11%-0.85%+26.15%+53.74% 34.78TCr
Weighted average by Cap. +0.26%-1.82%+39.91%+84.29%

Financials

2024 2025
Net sales 1.94TCr 20Cr 18Cr 16Cr 15Cr 28Cr 29Cr 194.47Cr 76Cr 951.58Cr 76Cr 74Cr 3.28TCr 2.11TCr 22Cr 19Cr 18Cr 16Cr 31Cr 31Cr 211Cr 83Cr 1.03TCr 82Cr 80Cr 3.55TCr
Net income 305.22Cr 3.17Cr 2.77Cr 2.56Cr 2.36Cr 4.44Cr 4.54Cr 31Cr 12Cr 149.49Cr 12Cr 12Cr 514.6Cr 266.79Cr 2.77Cr 2.42Cr 2.23Cr 2.06Cr 3.88Cr 3.97Cr 27Cr 11Cr 130.66Cr 10Cr 10Cr 449.8Cr
Net Debt -454.93Cr -4.72Cr -4.13Cr -3.81Cr -3.51Cr -6.62Cr -6.77Cr -46Cr -18Cr -222.81Cr -18Cr -17Cr -767Cr -514.96Cr -5.35Cr -4.67Cr -4.31Cr -3.97Cr -7.49Cr -7.66Cr -52Cr -20Cr -252.2Cr -20Cr -20Cr -868.21Cr
Logo FDC Limited
FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen Sodium, Miconazole Nitrate, Timolol Maleate, Amoxycillin + Clavulanic Acid, Rupatadine Fumarate, Salbutamol Sulphate, Kaolin Light/ Pectin, among others. The Company’s product offerings cover an extensive range of categories, including anti-infectives, gastrointestinal treatments, ophthalmic, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, respiratory care, gynecology, dermatology and analgesics. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
Employees
6,857
Date Price Change Volume
17/26/17 419.70 -0.52% 3,336
16/26/16 ₹421.90 -0.59% 3,524
15/26/15 ₹424.40 +0.68% 798
14/26/14 ₹421.55 -1.62% 2,647
13/26/13 ₹428.50 -0.81% 4,041
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B